OPKO Health (OPK) Reports Q2 Loss Per Share of 2c, Revenue Beats
Tweet
Share
E-mailGet Alerts OPK Hot Sheet
Price: $1.67 +3.09%
EPS Growth %: -333.3%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -333.3%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
OPKO Health (NYSE: OPK) reported Q1 EPS of ($0.02), may not compare to the analyst estimate of ($0.03). Revenue for the quarter came in at $291 million versus the consensus estimate of $266.3 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade
- Anthropic delays planned IPO from October to November - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
